COMPLIANCE INFO 1986 - 2016 - Laserfiche WebLink

Home Browse Search

State of California-Health and Welfare Ager Department of Health Services Page 5 of 7 pages RADIOACTIVE MATERIAL LICENSE License Number 1276-39 Amendment Number. 70 20. The licensee may use any commercially available device, acceptable to the U.S. Nuclear Regulatory Commission, an Agreement State or a Licensing State, for doing linearity tests of its dose calibrator provided the procedures described by the manufacturer of the linearity device are followed. 21. Nuclear medicine technology procedures shall be performed by nuclear medicine technologists pursuant to Title 17, California Code of Regulations, Subchapter 4.6. Such procedures shall be performed under the supervision of individuals listed as authorized users on this license who meet the criteria specified in Section 3 05 10. Certificates or special permits issued pursuant to Subchapter 4.6 shall be prominently displayed at the facility(ies) authorized on this license. 22. Treatment and management of patients receiving therapeutic quantities of unsealed radioactive materials shall be in accordance with guidance contained in Chapter 4, "Release from Hospital of Patients Containing Radioactive Material" National Council on Radiation Protection and Measurements (NCRP) Report No. 37, "Precautions in the Management of Patients Who Have Received Therapeutic Amounts of Radionuclides" (NCRP Publications, P.O. Box 30175, Washington, D.C. 20014). 23. Treatment and management of patients undergoing brachytherapy shall be in accordance with guidance contained in Chapter 5, "Safety Precautions in Clinical Application",National Council on Radiation Protection and Measurements (NCRP) Report No. 40, "Protection Against Radiation From Brachytherapy Sources" (NCRP Publications, P.O. Box 30175, Washington, D.C. 20014). 24. Notwithstanding the six-month test interval requirement of Section 30275 of Title 17, California Code of Regulations, medical Cesium-137 sources (3M Company Models 6500-6507 or Model 6D6C, and Isotope Products Model 67-800 or 67-820 series) possessed under this license may be tested for leakage and/or contamination at three- year intervals. 25. Remote afterloading device facilities shall be so constructed as to permit continuous observation of patients from outside the treatment room(s). 26. If there is a reason to suspect that the source position indicator or entrance door(s) interlock(s) is/are not functioning properly, use of the remote afterloading device(s) shall be discontinued until the condition has been corrected. A record of any such malfunction shall be made and maintained available for inspection. 27. Special Requirements for Remote Afterloading Device Spot-Checks and Calibration: (a) At intervals not to exceed daily or prior to use(if used less frequently),the following tests shall be performed: (1) Source position indicator(s). (2) Source positioning reproducibility,to within ±1 mm. (3) Inspection of guide tubes for kinks and other imperfections. (b) At intervals not to exceed monthly or prior to use (if used less frequently), the following tests shall be performed: (l) Accuracy of the timing device. (2) Source travel time error. (c) At each source loading and intervals not to exceed three months, (one month for Ir-192) thereafter, the licensee shall determine the dose accuracy to within±5 percent. 28. Remote afterloading devices authorized by this license shall not be operated unless the licensee has in his possession detailed written instructions specific for the make and model of the remote afterloading device.